It is shown that homocysteine accumulation in proximal tubular epithelial cells (PTECs) is a significant contributor to mitochondrial oxidative stress in DKD and the role of the lncPTEC/MTHFD1 axis in Hcy-mediated mitochondrial oxidative stress is elucidated, offering potential diagnostic biomarkers and therapeutic targets for DKD.
Abstract
Diabetic kidney disease (DKD) is a leading cause of end-stage kidney disease and chronic kidney disease. Oxidative stress, a key driver of renal fibrosis and a hallmark of DKD pathological changes, has been extensively studied for its role in DKD progression. However, its specific mechanisms remain unclear. Here, we show that homocysteine (Hcy) accumulation in proximal tubular epithelial cells (PTECs) is a significant contributor to mitochondrial oxidative stress in DKD. Through single-cell RNA sequencing (scRNA-seq) screening, we identify lncPTEC, a DKD-associated long non-coding RNA (lncRNA) from the PTEC cluster. Notably, we find that upregulated lncPTEC correlates with elevated albuminuria in DKD patients and exacerbates mitochondrial oxidative stress, epithelial-mesenchymal transition (EMT) and renal tubular fibrosis both in vitro and in vivo. Mechanistically, lncPTEC is transcriptionally upregulated by the transcription factor specificity protein 1 (SP1) under hyperglycemic conditions. Furthermore, lncPTEC directly interacts with the established key factor of Hcy metabolism, methylenetetrahydrofolate dehydrogenase 1 (MTHFD1), promoting its ubiquitination and degradation via the ubiquitination-related protein UBQLN1. This process leads to Hcy accumulation, mitochondrial oxidative stress, and subsequent DKD progression. Hence, our findings elucidate the role of the lncPTEC/MTHFD1 axis in Hcy-mediated mitochondrial oxidative stress, offering potential diagnostic biomarkers and therapeutic targets for DKD.
Comparison of single‐cell RNA sequencing data of kidney samples from healthy controls and DKD patients reveals a novel S100A1‐MDM2‐KLF15‐ID1 regulatory axis in DKD pathogenesis and suggests targeting S100A1 might be a potential therapy for proximal tubular injury in DKD.
Zhi-Tao Zeng, Jia-Zhen Shang, Shou-Yu Chai et al.· The FASEB Journal· 0 citations
It is demonstrated that the YOD1-KEAP1 axis mediates oxidative stress injury in RTECs and highlight that targeting YOD1 represents a potential treatment approach for DKD.
Qing-Qing Zhao, Ying Zhao, Shi-Jie Fan et al.· Acta Pharmacologica Sinica· 0 citations
Tubular EZH2 protects against DKD via inhibiting SHC1-driven oxidative stress via epigenetically suppresses the pro-oxidative mediator SHC1, and rescues the exacerbated fibrotic response and oxidative damage triggered by pharmacological EZH2 suppression under high-glucose conditions.
It is demonstrated that SDHB is down-regulated in fibrotic kidneys, and mechanistic insights into how TCA cycle disruptions and mtRNA leakage interactions drive renal inflammation are provided, suggesting SDHB as a potential therapeutic target for renal fibrosis.
Zi-Jing Zhu, Ping Chen, Hong-Xin Shu et al.· Metabolism: Clinical and Exp...· 0 citations
It is demonstrated that Nrf2 deficiency exacerbates AKI-CKD progression through redox imbalance and ferroptosis-mediated maladaptive repair, and targeting Keap1-Nrf2 with 6K protects against renal injury and fibrosis, highlighting its therapeutic potential for kidney diseases.
Yi-Ming Wang, Yi Sun, Ting Zhou et al.· Redox Biology· 0 citations
It is found that SGK2 suppresses tubular ferroptosis in DKD through NEDD4L-dependent K48-linked ubiquitination and proteasomal degradation of ACSL4, thereby limiting lipid peroxidation and protecting the renal tubules.
Fei Zhang, An-Dong Zhang, Li-Wen Wang et al.· Antioxidants and Redox Signa...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.